Diisopromine

Diisopromine

Clinical data
ATC code	A03AX02 (WHO)
Identifiers
IUPAC name N-(3,3-diphenylpropyl)-N-propan-2-yl-propan-2-amine
CAS Number	5966-41-6
PubChem CID	22262
E number	{{#property:P628}}
ECHA InfoCard	{{#property:P2566}}
Chemical and physical data
Formula	C21H29N
Molar mass	295.462 g/mol

WikiDoc Resources for Diisopromine
Articles
Most recent articles on Diisopromine Most cited articles on Diisopromine Review articles on Diisopromine Articles on Diisopromine in N Eng J Med, Lancet, BMJ
Media
Powerpoint slides on Diisopromine Images of Diisopromine Photos of Diisopromine Podcasts & MP3s on Diisopromine Videos on Diisopromine
Evidence Based Medicine
Cochrane Collaboration on Diisopromine Bandolier on Diisopromine TRIP on Diisopromine
Clinical Trials
Ongoing Trials on Diisopromine at Clinical Trials.gov Trial results on Diisopromine Clinical Trials on Diisopromine at Google
Guidelines / Policies / Govt
US National Guidelines Clearinghouse on Diisopromine NICE Guidance on Diisopromine NHS PRODIGY Guidance FDA on Diisopromine CDC on Diisopromine
Books
Books on Diisopromine
News
Diisopromine in the news Be alerted to news on Diisopromine News trends on Diisopromine
Commentary
Blogs on Diisopromine
Definitions
Definitions of Diisopromine
Patient Resources / Community
Patient resources on Diisopromine Discussion groups on Diisopromine Patient Handouts on Diisopromine Directions to Hospitals Treating Diisopromine Risk calculators and risk factors for Diisopromine
Healthcare Provider Resources
Symptoms of Diisopromine Causes & Risk Factors for Diisopromine Diagnostic studies for Diisopromine Treatment of Diisopromine
Continuing Medical Education (CME)
CME Programs on Diisopromine
International
Diisopromine en Espanol Diisopromine en Francais
Business
Diisopromine in the Marketplace Patents on Diisopromine
Experimental / Informatics
List of terms related to Diisopromine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Diisopromine or disoprominum, usually as the hydrochloride salt, is a synthetic spasmolytic which neutralizes spastic conditions of the biliary tract and of the sphincter of Oddi. It was discovered at Janssen Pharmaceutica in 1955.

References

• Diisopromine (NCBI, PubChem)

Template:Pharma-stub Template:Drugs for functional gastrointestinal disorders